Medicus Pharma Ltd. — Director's Dealing 2025

Jan 24, 2025

SEC Form 3/A — Form 3/A

Issuer: Medicus Pharma Ltd. (MDCX)
CIK: 0001997296
Period of Report: 2024-12-31

Reporting Person: Kaiser Larry (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$2.75	2029-12-17	Common Shares (15000)		Direct

Footnotes

F1: The option was granted on December 17, 2024. The option is scheduled to vest quarterly in four equal installments over one year.

F2: This amendment is being filed to include options that were inadvertently omitted from the Form 3 filed by the Reporting Person on December 31, 2024.

F3: Represents an exercise price of $3.95 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.4379 reported by the Bank of Canada on December 30, 2024.